Operator: Good afternoon and thank you for standing by. Welcome to Xencor’s Third Quarter 2023 Conference Call. Please be advised that this call is going to be recorded at the company’s request.
07.11.2023 - Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of patients with cancer and autoimmune diseases, today reported financial results for the third quarter ended .
Xencor, Inc. (NASDAQ:XNCR) Q2 2023 Earnings Call Transcript August 6, 2023 Operator: Good afternoon, and thank you for standing by. Welcome to Xencor’s Second Quarter 2023 Conference Call. After the speakers’ presentation there will be a question-and-answer session. [Operator Instructions] Please be advised that this call is going to be recorded at the company’s request. […]
Operator: Good afternoon, and thank you for standing by. Welcome to Xencor s Second Quarter 2023 Conference Call. After the speakers presentation there will be a question-and-answer session.